As on Wednesday, Definium Therapeutics Inc (NASDAQ: DFTX) got off with the flyer as it spiked 2.20% to $17.15, before settling in for the price of $16.78 at the close. Taking a more long-term approach, DFTX posted a 52-week range of $4.70-$17.14.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 12.11%. Meanwhile, its Annual Earning per share during the time was 12.11%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -29.53%. This publicly-traded company’s shares outstanding now amounts to $76.77 million, simultaneously with a float of $73.44 million. The organization now has a market capitalization sitting at $1.69 billion.
Definium Therapeutics Inc (DFTX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Definium Therapeutics Inc’s current insider ownership accounts for 2.80%, in contrast to 51.91% institutional ownership. According to the most recent insider trade that took place on Dec 26 ’25, this organization’s Chief Medical Officer sold 5,600 shares at the rate of 13.15, making the entire transaction reach 73,623 in total value, affecting insider ownership by 425,025. Preceding that transaction, on Dec 26 ’25, Company’s Chief Executive Officer sold 25,791 for 13.15, making the whole transaction’s value amount to 339,072. This particular insider is now the holder of 778,477 in total.
Definium Therapeutics Inc (DFTX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
Definium Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -29.53% and is forecasted to reach -1.78 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -1.00% through the next 5 years, which can be compared against the 12.11% growth it accomplished over the previous five years trading on the market.
Definium Therapeutics Inc (NASDAQ: DFTX) Trading Performance Indicators
Let’s observe the current performance indicators for Definium Therapeutics Inc (DFTX). It’s Quick Ratio in the last reported quarter now stands at 3.30.
In the same vein, DFTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.97, a figure that is expected to reach -0.50 in the next quarter, and analysts are predicting that it will be -1.78 at the market close of one year from today.
